Seres Therapeutics Inc (NASDAQ:MCRB) Consolidated Diluted EPS At -2.3279

0

For the year ended 2015-12-31 Seres Therapeutics Inc (NASDAQ:MCRB) basic consolidated EPS came $-2.3279. Furthermore, for the quarter closed 2015-12-31, it was $-2.3279.

Consolidated diluted EPS

Seres Therapeutics Inc (NASDAQ:MCRB) consolidated diluted EPS was -2.3279 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it stood at $-2.3279.

EPS contribution from parent

Seres Therapeutics Inc (NASDAQ:MCRB) basic EPS was $-2.3279 for the year ended 2015-12-31 from its parent entity. It was $-2.3279 for the quarter closed 2015-12-31.

EPS from continuing operations

Seres Therapeutics Inc (NASDAQ:MCRB) EPS from continuing activities was $-2.3279 for the fiscal ended 2015-12-31. For the quarter ended 2015-12-31, this figure was $-2.3279.

Basic net EPS

Seres Therapeutics Inc (NASDAQ:MCRB) basic net EPS was $-2.33 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it came at $-2.33.

Diluted EPS from parent

Seres Therapeutics Inc (NASDAQ:MCRB) diluted EPS from parent entity came at $-2.3279 for the year ended 2015-12-31. For the quarter ended 2015-12-31 it was $-2.3279.

Net diluted EPS

Seres Therapeutics Inc (NASDAQ:MCRB) net diluted EPS was $-2.33 for the fiscal closed 2015-12-31. For the quarter ended 2015-12-31, net diluted EPS was $-2.33.

Seres Therapeutics Inc (NASDAQ:MCRB) net basic EPS was $-2.33 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it was $-2.33.

Basic diluted EPS

Seres Therapeutics Inc (NASDAQ:MCRB) basic diluted EPS was $-0.5028 for the quarter ended 2015-12-31. For the year ended 2015-12-31, basic diluted EPS was $-0.5028.

For the year ended 2015-12-31, basic shares outstanding were 23.532 while for the quarter ended 2015-12-31 is 23.532.

For the fiscal ended 2015-12-31, the diluted outstanding shares were 23.532 and for the quarter ended 2015-12-31 it was 23.532. Earnings per share and diluted EPS are profitability metrics used in fundamental analysis of firms. EPS just takes into account a firm’s common shares, while diluted EPS considers all convertible securities. Per-share earnings measure the quantum of a company’s earnings on a per share basis. Basic EPS does not consider any dilutive impact that convertible securities leave on EPS. On contrary, diluted EPS is a tool used in fundamental study to gauge a firm’s quality of EPS, assuming there is conversion of all convertible securities.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 36 times, 1 visits today)